Clinical Trials

Clinical Trial to Assess Pharmacokinetic Parameters and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients.

Nanogen Pharmaceutical Biotechnology Joint Stock Company